TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.

Matteo Dugo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.